Women’s heart health, GLP-1 coverage, and midlife cardiovascular risk are raising new benefits questions for employers.
LucyRx can help you think through the issue, understand what data may matter, and identify the right next step before making benefit decisions.
The first step is understanding the population.
Start a conversation
A conversation with LucyRx can help employers think through:
Cardiovascular disease is the leading cause of death in women.
For many women, risk begins to rise in midlife, during perimenopause and menopause. At the same time, many employer plans still evaluate GLP-1 coverage through a diabetes or weight-loss lens.
Certain GLP-1s now carry an FDA-approved cardiovascular indication for adults with established cardiovascular disease and overweight or obesity. That creates a more specific benefits question for employers.
This is not a case for broad GLP-1 coverage. It is a reason to step back and ask what the plan should understand before making a benefit decision.
LucyRx helps employers make complex prescription benefit decisions clearer.
We can help employers think through:
The goal is not to rush to a coverage change.
The goal is to help employers ask better questions and make clearer decisions.
That is okay. This can start with a simple conversation.
If it makes sense to go deeper, LucyRx can discuss what information may be useful to review and what next steps may fit your goals, timing, and available data.
No benefit change is required to start the conversation.
Complete the form and a LucyRx team member will follow up to learn more about your goals.